Conmed (CNMD) Tops Q1 EPS by 8c; Hikes FY22 Revenue Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
CONMED Corporation Announces First Quarter 2022 Financial Results
May 4, 2022 4:05 PM EDTLARGO, Fla.--(BUSINESS WIRE)-- CONMED Corporation (NYSE: CNMD) today announced financial results for the first quarter ended March 31, 2022.
First Quarter 2022 Highlights
Sales of $242.3 million increased 4.1% year over year as reported and 4.3% in constant currency. Domestic revenue increased 5.9% year over year. International revenue increased 2.2% year over year as reported and 2.6% in constant currency. Diluted net earnings per share (GAAP) were $0.47, an increase of 51.6% over the first quarter of 2021. Adjusted diluted net earnings per share(1) were $0.70, an... More